TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy.

Denton, Mark D

TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. [electronic resource] - Transplantation Oct 2004 - 1218-21 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.

0041-1337

10.1097/01.tp.0000137266.30134.02 doi


Abdomen
Angiogenesis Inhibitors--administration & dosage
Animals
Coronary Disease--etiology
Cyclohexanes
Cyclosporine--administration & dosage
Drug Administration Schedule
Drug Therapy, Combination
Graft Survival--drug effects
Heart Transplantation--adverse effects
Male
O-(Chloroacetylcarbamoyl)fumagillol
Rats
Rats, Inbred F344
Rats, Inbred Lew
Sesquiterpenes--administration & dosage
Transplantation, Heterotopic